• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 2, Issue 2
  3. Author

Online ISSN: 2515-8260

Volume2, Issue2

Novel approaches for the supportive extracorporeal therapy of sepsis: Towards personalized treatment

    Viktoria Weber

European Journal of Molecular & Clinical Medicine, 2015, Volume 2, Issue 2, Pages 65-66

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Sepsis and sepsis-associated multiple organ failure are associated with extensive tissue damage caused by over-activation of the innate immune system and by the excessive release of inflammatory mediators. The development of targeted therapies for sepsis remains a major challenge due to the complex network of inflammatory mediators involved in the septic process. Early detection and timely therapeutic intervention are crucial for improved outcome of patients with sepsis. Currently however, the diagnosis of sepsis mostly relies on general symptoms. Taking into account the extreme heterogeneity of septic patients, the application of supportive extracorporeal therapies to modulate the concentration of inflammatory mediators requires diagnostic tools to monitor the inflammatory profile of the patients in order to identify the optimal time window for application of supportive therapies. Here, we report on the development of extracorporeal adsorption systems for cytokine modulation and on the development and validation of a novel array technology to detect markers of inflammation (interleukins 6 and 10, Abstracts / New Horizons in Translational Medicine 2 (2015) 55–71 65 C-reactive protein, procalcitonin, serum amyloid A) in a bedside-approach (detection from whole blood samples within 30 min)
Keywords:
    We demonstrate that the modulation of inflammatory mediators in septic plasma by means of selective adsorption significantly reduces endothelial activation in a cell culture model. We also discuss the role of extracellular microvesicles as markers and as potential targets for therapy
  • PDF (70 K)
  • XML
(2015). Novel approaches for the supportive extracorporeal therapy of sepsis: Towards personalized treatment. European Journal of Molecular & Clinical Medicine, 2(2), 65-66.
Viktoria Weber. "Novel approaches for the supportive extracorporeal therapy of sepsis: Towards personalized treatment". European Journal of Molecular & Clinical Medicine, 2, 2, 2015, 65-66.
(2015). 'Novel approaches for the supportive extracorporeal therapy of sepsis: Towards personalized treatment', European Journal of Molecular & Clinical Medicine, 2(2), pp. 65-66.
Novel approaches for the supportive extracorporeal therapy of sepsis: Towards personalized treatment. European Journal of Molecular & Clinical Medicine, 2015; 2(2): 65-66.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 38
  • PDF Download: 73
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  info@ejmcm.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

Editorial Team:  editor@ejmcm.com

For Special Issue Proposal : chiefeditor.ejmcm@gmail.com / info@ejmcm.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus